Results for tag: "Pleurodynia Drug"

Pleurodynia is a type of respiratory disorder that is characterized by chest pain and tenderness. It is caused by a virus, usually the Coxsackievirus, and is also known as “the epidemic of the summer”. Treatment for pleurodynia is mainly supportive, with the use of analgesics and anti-inflammatory drugs. In some cases, antibiotics may be prescribed to treat any secondary bacterial infections. The pleurodynia drug market is a subset of the larger respiratory drug market. It includes drugs used to treat pleurodynia, such as analgesics, anti-inflammatory drugs, and antibiotics. These drugs are used to reduce pain and inflammation, as well as to treat any secondary bacterial infections. Some companies in the pleurodynia drug market include Pfizer, Merck, GlaxoSmithKline, Novartis, and Sanofi. These companies produce a variety of drugs used to treat pleurodynia, including analgesics, anti-inflammatory drugs, and antibiotics. Show Less Read more